Literature DB >> 31222861

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.

Mette Reilev1,2, Anton Pottegård1, Jesper Lykkegaard2, Jens Søndergaard2, Truls S Ingebrigtsen3, Jesper Hallas1.   

Abstract

BACKGROUND AND
OBJECTIVE: Acute exacerbations in chronic obstructive pulmonary disease (COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether the risk of having MACE was transiently increased following the onset of an acute COPD exacerbation.
METHODS: We conducted a nationwide, register-based study from 1997 to 2014 comprising individuals with an acute COPD exacerbation followed by a MACE (acute myocardial infarction (MI), stroke or cardiovascular death). Using the case-crossover design, we estimated odds ratios (OR) for the association between acute exacerbations of COPD and MACE as well as for single outcomes (acute MI, stroke and cardiovascular death), different levels of severity of exacerbations and within patient subgroups.
RESULTS: We identified 118 807 cases with a MACE preceded by an exacerbation. Overall, the risk of MACE increased almost fourfold following the onset of an acute exacerbation compared to periods without exacerbations in the same individuals (OR: 3.70; 95% CI: 3.60-3.80). The associations were consistent for single outcomes (acute MI, OR: 3.57; cardiovascular death, OR: 4.33; and stroke, OR: 2.78) and particularly strong associations were demonstrated for severe exacerbations (OR: 5.92) and the oldest individuals (OR: 4.18).
CONCLUSION: The risk of MACE increased substantially following the onset of an acute exacerbation. This highlights that prevention of cardiac events is an important goal in the management of COPD. Attention should be paid to detecting cardiovascular disease following acute COPD exacerbations.
© 2019 Asian Pacific Society of Respirology.

Entities:  

Keywords:  acute chronic obstructive pulmonary disease exacerbations; chronic obstructive pulmonary disease; epidemiological studies; myocardial infarction; stroke

Mesh:

Year:  2019        PMID: 31222861     DOI: 10.1111/resp.13620

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

1.  Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.

Authors:  Mathias Damkjær; Kjell Håkansson; Thomas Kallemose; Charlotte Suppli Ulrik; Nina Godtfredsen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-05

2.  Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap.

Authors:  Truls Sylvan Ingebrigtsen; Jacob Louis Marott; Jørgen Vestbo; Børge Grønne Nordestgaard; Peter Lange
Journal:  BMJ Open Respir Res       Date:  2020-02

3.  Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities.

Authors:  Ravi Kalhan; David Slade; Riju Ray; Chad Moretz; Guillaume Germain; François Laliberté; Qin Shen; Mei Sheng Duh; Sean Dale MacKnight; Beth Hahn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-22

4.  Association between Chronic Obstructive Pulmonary Disease and Ménière's Disease: A Nested Case-Control Study Using a National Health Screening Cohort.

Authors:  So-Young Kim; Chang-Ho Lee; Dae-Myoung Yoo; Chan-Yang Min; Hyo-Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2021-04-24       Impact factor: 3.390

Review 5.  Towards precision in defining COPD exacerbations.

Authors:  Christine R Jenkins
Journal:  Breathe (Sheff)       Date:  2021-09

6.  Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study.

Authors:  Yen-Ju Chen; Shih-Chia Liu; Kuo-Lung Lai; Kuo-Tung Tang; Ching-Heng Lin; Yi-Ming Chen; Chih-Wei Tseng; Yu-Mei Chang; Donald F Gotcher; Chuang-Chun Chiou; Shao-Jen Weng; Hsin-Hua Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-08-26       Impact factor: 5.346

7.  Predicting the Risk of Unplanned Readmission at 30 Days After PCI: Development and Validation of a New Predictive Nomogram.

Authors:  Wenjun Xu; Hui Tu; Xiaoyun Xiong; Ying Peng; Ting Cheng
Journal:  Clin Interv Aging       Date:  2022-07-05       Impact factor: 3.829

8.  Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.

Authors:  Hana Müllerová; Jonathan Marshall; Enrico de Nigris; Precil Varghese; Nick Pooley; Nina Embleton; Clementine Nordon; Zoe Marjenberg
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

9.  Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika® and Acapella® Devices.

Authors:  Jenny Tse; Keiko Wada; Yi Wang; Dominic Coppolo; Vladimir Kushnarev; Jason Suggett
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.